Anne Horgan

Anne Horgan is a Partner focusing on biotech and biopharma investments.

Prior to joining CIC Anne was a Partner at Advent France Biotechnology, a Paris-based venture capital firm specializing in Life Sciences seed investments, and Senior Associate at Sofinnova Partners.

Anne brings 17 years’ experience, acquired as Business Development Executive at Cancer Research Technology and Senior Medicinal Chemist at Cambridge Biotechnology (now part of Benevolent AI). Anne’s experience includes equity financing (seed and series A), technology transfer and scouting, business development and biotech R&D.

Anne carried out postdoctoral research at Yale University after her PhD in synthetic organic chemistry from the University of Bristol. She holds a diplôme d’ingénieur (Chemistry) from the Institut National des Sciences Appliquées de Rouen, authored several peer-reviewed papers and is an inventor on eight patent families.